Cargando…
Aspartate β-hydroxylase disrupts mitochondrial DNA stability and function in hepatocellular carcinoma
The mechanism of aberrant mitochondrial genome and function in hepatocellular carcinoma (HCC) remains largely unknown. Our previous study demonstrated an increased expression of aspartate β-hydroxylase (ASPH) in HCC tissues, which was associated with tumor invasiveness and a worse prognosis. Current...
Autores principales: | Tang, C, Hou, Y, Wang, H, Wang, K, Xiang, H, Wan, X, Xia, Y, Li, J, Wei, W, Xu, S, Lei, Z, Pawlik, T M, Wu, M, Shen, F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541716/ https://www.ncbi.nlm.nih.gov/pubmed/28714949 http://dx.doi.org/10.1038/oncsis.2017.64 |
Ejemplares similares
-
Diverse molecular functions of aspartate β-hydroxylase in cancer
por: Zheng, Wenqian, et al.
Publicado: (2020) -
Aspartate β-hydroxylase as a target for cancer therapy
por: Kanwal, Madiha, et al.
Publicado: (2020) -
Construction and Characterization of Adenovirus Vectors Encoding Aspartate-β-Hydroxylase to Preliminary Application in Immunotherapy of Hepatocellular Carcinoma
por: Zhou, Yujiao, et al.
Publicado: (2018) -
Hydroxylase Activity of ASPH Promotes Hepatocellular Carcinoma Metastasis Through Epithelial-to-Mesenchymal Transition Pathway
por: Zou, Qifei, et al.
Publicado: (2018) -
Aspartate β-Hydroxylase Serves as a Prognostic Biomarker for Neoadjuvant Chemotherapy in Gastric Cancer
por: Gan, Xuejun, et al.
Publicado: (2023)